Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
Emory University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Ann & Robert H Lurie Children's Hospital of Chicago